Abstract
The initial diagnosis of prostatic cancer has typically relied on digital rectal examination which is, compared with other screening modalities, a noninvasive, cost effective, and highly reliable screening technique (Guinan et al. 1980; Chodak and Schoenberg 1984). Despite these advantages, over 50% of cases of prostatic cancer are diagnosed only after the disease has progressed beyond curability. Because earlier detection would allow institution of curative therapy, the search for imaging modalities capable of detecting intraprostatic lesions and delineating local extension has been extensive. This review focuses both on current imaging methods and on those likely to be useful in the future for the diagnosis and pelvic staging of prostatic cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bartsch G, Egender G, Hubscher H et al. (1982) Sonometrics of the prostate. J Urol 127: 1119–1121
Beaney RP (1984) Positron emission tomography in the study of human tumors. Semin Nucl Med 14: 324–341
Bottomley PA (1983) Nuclear magnetic resonance: beyond physical imaging. IEEE Spectrum 20 (2): 32–38
Brasch RC, London DA, Wesbey GE et al. (1983) Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 147: 773–779
Brasch RC, Weinemann HJ, Wesbey GE (1984) Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR 142: 625–630
Brooman PJC, Griffiths GJ, Roberts E (1981) Per rectal ultrasound in the investigation of prostatic disease. Clin Radiol 32: 669–676
Bryan PJ, Butler HE, Lipuma JP (1983) NMR scanning of the pelvis: initial experience with a 0.3T system. AJR 141: 1111–1118
Bryan PH, Butler HE, Lipuma JP (1984) Magnetic resonance imaging of the pelvis. Radiol Clin North Am 22: 897–915
Budinger TF, Lauterbur PC (1984) Nuclear magnetic resonance technology for medical studies. Science 226: 288–298
Buonocore E, Hesemann C, Pavlicek W, Montie (1984) Clinical and in vitro magnetic resonance imaging of prostatic carcinoma. AJR 143: 1267–1272
Burks DD, Drolshogen LF, Fleischer AC et al. (1986) Transrectal sonography of benign and malignant prostatic lesions. AJR 146: 1187–1191
Carpenter PJ, Schroder FH (1984) Transrectal ultrasonography in the followup of prostatic carcinoma patients: a new prognostic parameter. J Urol 131: 903–905
Che TM, Kuriyama M, Johnson E et al. (1984) Circulating antibody to prostate antigen in patients with prostate cancer. Transplant Proc 16: 481–485
Chodak GW, Schoenberg HW (1984) Early detection of prostate cancer by routine screening. JAMA 252: 3261–3264
Correa RJ, Kidd CR, Burnett L et al. (1981) Percutaneous pelvic lymph node aspiration in carcinoma of the prostate. J Urol 126: 190–191
Dahnert WF, Hamper UM, Eggleston JC et al. (1986) Prostatic evolution by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma. Radiology 158: 97–102
Demas BE, Hricak HH, Williams RD (1985) Magnetic resonance imaging in the evaluation of urologic malignancies. Semin Urol 3: 27–33
Denkhaus H, Dierkopf W, Grabbe E (1983) Comparative study of suprapubic sonography and computed tomography for staging of prostatic carcinoma. Urol Rad. 5: 1–9
Dooms GC, Hricak HH, Crooks LE et al. (1984) Magnetic resonance imaging of the lymph nodes: comparison with CT. Radiology 153: 181–188
Efrimidis SC, Dan SJ, Nieburgs H et al. (1981) Carcinoma of the prostate: lymph node aspiration for staging. AJR 136: 489–492
Egender G, Rapf C, Feichtenger I et al. (1984) Comparative histopathologic and sonomorphological prostate studies. ROFO 140: 60–66
Ehman RL, Wesbey GE, Moon KL et al. (1985) Enhanced MRI of tumors utilizing a new nitroxyl spin label contrast agent. J MRI 3: 89–97
Emory TH, Reinke DB, Hill AL et al. (1983) Use of CT to reduce understaging in prostatic cancer: comparison with conventional staging techniques. AJR 141: 351–354
Fair WR, Kadmon D (1983) Carcinoma of the prostate: diagnosis and staging. World J Urol 1: 3–11
Fornage BD, Touche DH, Deglaire M et al. (1983) Real-time ultrasound-guided prostatic biopsy using a new transrectal linear-array probe. Radiology 146: 547–550
Fritzsche PJ, Axford PD, Ching VC, et al. (1983) Correlation of transrectal sonographic findings in patients with suspected and unsuspected prostatic disease. J Urol 130: 272–274
Gammelguard J, Holm HH (1980) Transurethral and transrectal ultrasonic scanning in urology. J Urol 124: 863–868
Golimbu M, Morales P, Al-Askori S et al. (1981) CAT scanning in staging of prostate cancer. Urology 18: 305–308
Gothlin JH, Hoien L (1980) Percutaneous fine-needle biopsy of radiographically normal lymph nodes in the staging of prostatic carcinoma. Radiology 141: 351–354
Guinan P, Bush I, Ray V et al. (1980) The accuracy of rectal examination in the diagnosis of prostate carcinoma. N Engl J Med 303: 499–503
Harada K, Tanahashi Y, Igari D et al. (1980) Clinical evaluation of inside echo patterns in gray scale prostatic echography. J Urol 124: 216–220
Holm HH, Juul N, Pederson JF (1983) Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130: 283–286
Kadmon D, Mahle D, Heston WDW et al. (1985) Effect of estrogen and androgen administration on alpha DCMO-enhanced putrescine uptake by the rat prostate. Prostate 6: 343–349
Kidd R, Crane RD, Doil DH (1984) Lymphangiography and fine-needle aspiration biopsy: ineffective for staging early prostate cancer. AJR 142: 1007–1112
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497
Lee JKT, Heiken JP, Ling D et al. (1984) Magnetic resonance imaging of abdominal and pelvic lymphadenopathy. Radiology 153: 181–188
Lee F, Gray JM, McCleary RD et al. (1986) Prostatic evolution by transrectal sonography: criteria of early diagnosis. Radiology 158: 91–95
Levine MS, Arger PH, Coleman BG et al. (1981) Detecting lymphatic metastases from prostatic carcinoma: superiority of CT. AJR 137: 207–211
Loening SA, Schmidt JD, Brown RC et al. (1977) A comparison between lymphangiography and pelvic node dissection in the staging of prostatic cancer. J Urol 117: 752–756
Lowe DH, Handley HH, Schmidt J et al. (1984) A human monoclonal antibody reactive with human prostate. J Urol 132: 780–785
McNeal JE (1968) Regional morphology and pathology of the prostate. Am J Clin Pathol 49: 347–357
Merrin C, Wajsman Z, Baumgartner G et al. (1977) The clinical value of lymphangiography: Are the nodes surrounding the obturator nodes visualized? J Urol 117: 742–744
Miller TR, Siegel BA, Fair WR et al. (1978) Imaging of canine tumors with uC-methyl-putrescine. Radiology 129: 221–223
Morgan CJ, Hendee WR (1984) Magnetic resonsance spectroscopy. In: Morgan CJ, Hendee WR (eds) Introduction to magnetic resonance 9. Multimedia Publishing, Denver, p 125
Morgan CL, Calkins RF, Cavalcanti EJ (1981) Computed tomography in the evaluation, staging and therapy of carcinoma of the bladder and prostate. Radiology 140: 751–761
Moris JM, Evans AE, McLaughlin AC et al. (1985) 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. N Engl J Med 312: 1500–1505
Phelps ME, Mazziatta JC (1985) Positron emission tomography: human brain function and biochemistry. Science 228: 799–809
Pontes JE, Chu TM, Slack N et al. (1982) Serum prostatic antigen measurement in localized prostatic cancer: correlation with clinical course. J Urol 128: 1216–1218
Poon PY, McCollum RW, Henkelman MM (1985) Magnetic resonance imaging of the prostate. Radiology 154: 143–149
Prando A, Wallace S, Van Eschenbach AC et al. (1979) Lymphangiography in staging carcinoma of the prostate. Radiology 131: 641–645
Pykett IL (1982) NMR imaging in medicine. Sci Am 246: 78–88
Rifkin MD, Kurtz AB, Goldberg BB (1983) Sonographically guided transperineal prostatic biopsy: preliminary experience with a longitudinal linear array transducer. AJR 140: 745–748
Rifkin MD, Friedland GW, Shortliffe L (1986) Prostatic evaluation by transrectal endosonography: detection of carcinoma. Radiology 158: 85–90
Ross B, Smith M, Marshall V et al. (1984) Monitoring responses to chemotherapy of intact human tumors by 31P nuclear magnetic resonance. Lancet 1: 641–646
Runge VM, Clanton JA, Herzer WA et al. (1984) Intravascular contrast agents suitable for magnetic resonance imaging. Radiology 153: 171–176
Sawczuk IS, deVere White R, Gold R et al. (1983) Sensitivity of computed tomography in evaluation of pelvic lymph node metastases from carcinoma of bladder and prostate. Urology 21: 81–84
Shankagiri PG, Walsh JW, Hazra TA (1982) Role of computed tomography in the evaluation and management of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 8: 283–287
Smith FW (1985) Nuclear magnetic resonance proton imaging in cancer. Eur J Clin Oncol 21: 379–387
Sobol RE, Dillman RO, Halpern S et al. (1983) Sero therapy and radio immunodetection of tumors with monoclonal antibodies. In: Molog PJ, Nicolson GL (eds) Cellular oncology—new approaches in biology, diagnosis and treatment. Praeger, New York
Spirnak JP, Resnick MI (1984) Transrectal ultrasonography. Urology 23: 461–467
Steyn JH, Smith FW (1982) Nuclear magnetic resonance imaging of the prostate. Br J Urol 54: 726–728
Strand M, Scheinberg DA (1983) Monoclonal antibody conjugates for diagnostic imaging and therapy. In: Boss BD, Langman R, Towbridge I, Dulbecco R (eds) Monoclonal antibodies and cancer. Academic Press, New York
Velthoven RV, Vandewalle JC, Lavieter-Nobre et al. (1984) Early diagnosis of prostatic carcinoma: advantages and limits of transrectal ultrasonic examinations. Abstract from 6th EAU Congress, Copenhagen
Vessella RL, Chiou RK, Lange PH (1985) Monoclonal antibodies in urology: review of reactivities and applications in diagnosis, staging, and therapy. Semin Urol 3: 158–167
Walsh JW, Amendola MA, Konerding KF et al. (1980) Computed tomographic detection of pelvic and inguinal lymph-node metastases from primary and recurrent pelvic malignant disease. Radiology 137: 157–166
Watanabe H et al. (1968) Diagnostic application of the ultrasonotomography for the prostate. Jpn J Urol 59: 273–279
Watanabe H, Saitoh M, Mishina T (1977) Mass screening program for prostatic disease with transrectal ultrasonotomography. J Urol 117: 746–748
Weinerman PM, Arger PH, Pollack HM (1982) CT evaluation of bladder and prostate neoplasms. Urol Radiol 4: 105–114
Weinerman PM, Arger PH, Coleman BG et al. (1983) Pelvic adenopathy from bladder and prostate carcinoma: detection by rapid sequence computed tomography. AJR 140: 95–99
Williams RD, Hricak HH (1984) Magnetic resonance imaging in urology. J Urol 132: 641–649
Williams RD, Dunn V, Yousef MA, Brown RC (1986) Staging of pelvic malignancies by MRI. J Urol 135: 244A
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bretan, P.N., Williams, R.D. (1987). Imaging Techniques in the Diagnosis and Pelvic Staging of Prostatic Cancer. In: Bruce, A.W., Trachtenberg, J. (eds) Adenocarcinoma of the Prostate. Clinical Practice in Urology. Springer, London. https://doi.org/10.1007/978-1-4471-1398-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1398-0_5
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1400-0
Online ISBN: 978-1-4471-1398-0
eBook Packages: Springer Book Archive